Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

CollPlant Biotechnologies (CLGN) Return on Sales (2017 - 2025)

CollPlant Biotechnologies filings provide 9 years of Return on Sales readings, the most recent being 0.47% for Q4 2025.

  • On a quarterly basis, Return on Sales fell 24.0% to 0.47% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.01%, a 2.0% decrease, with the full-year FY2025 number at 0.05%, up 27.0% from a year prior.
  • Return on Sales hit 0.47% in Q4 2025 for CollPlant Biotechnologies, down from 0.45% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.46% in Q1 2024 to a low of 10.82% in Q3 2024.
  • Median Return on Sales over the past 5 years was 0.04% (2021), compared with a mean of 0.68%.
  • Biggest five-year swings in Return on Sales: crashed -2617bps in 2021 and later surged 1036bps in 2025.
  • CollPlant Biotechnologies' Return on Sales stood at 0.12% in 2021, then crashed by -557bps to 0.81% in 2022, then skyrocketed by 82bps to 0.15% in 2023, then crashed by -57bps to 0.23% in 2024, then plummeted by -104bps to 0.47% in 2025.
  • The last three reported values for Return on Sales were 0.47% (Q4 2025), 0.45% (Q3 2025), and 0.18% (Q2 2025) per Business Quant data.